Cell and Gene Therapy Bio-manufacturing Market Top Companies Study - Getinge AB, Infors AG, Lonza Group Ltd, Merck KGaA, Miltenyi Biotec B.V. & Co. K.G., PIERRE GUERIN.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Bio-manufacturing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Equipment, And Software Solutions), Usage (Commercial-Stage Manufacturing And Research-Stage Manufacturing), Application (Upstream Processing, Harvesting, And Downstream Processing), And End-User (Life Science Companies, Contract Research Organizations (Cros), Contract Manufacturing Organizations (CMOs), And Cell Banks)- Market Outlook And Industry Analysis 2031"

The global cell and gene therapy bio-manufacturing market is estimated to reach over 40.2 billion by the year 2031, exhibiting a CAGR of 11.4% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1692

The global cell and gene therapy bio-manufacturing market is expected to witness substantial growth, primarily driven by the increasing number of approved therapies and the escalating demand for advanced manufacturing infrastructure. The broadening spectrum of target indications for these therapies is also accelerating the need for large-scale bio-manufacturing capabilities. This expansion is further supported by significant capital investments from both governmental bodies and prominent industry stakeholders. Over the past decade, an estimated USD 2.3 billion has been directed toward gene therapy companies, reflecting strong engagement from leading pharmaceutical and biotechnology firms in the advancement of gene therapy technologies.

Moreover, contract development and manufacturing organizations (CDMOs/CMOs), along with internal manufacturing units, are increasingly identifying gene and cell therapy as a strategic growth area. The pharmaceutical and biotech industries are maintaining a high level of investment in research and development within this sector. According to the U.S. Food and Drug Administration (USFDA), there has been a notable rise in the number of cell and gene therapy products entering early-stage development pipelines. Collectively, these dynamics are projected to drive robust market expansion over the forecast period.

List of Prominent Players in the Cell and Gene Therapy Bio-manufacturing Market:
• Becton, Dickinson and Company
• Endress+Hauser Group Services AG (Analytik Jena GmbH)
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• General Electric Company (G.E. Healthcare)
• Getinge AB
• Infors AG
• Lonza Group Ltd
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• PIERRE GUERIN
• Sartorius AG (Sartorius Stedim Biotech S.A.)
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Market Dynamics:
Drivers-
The growing incidence of cancer and other targeted diseases, combined with increasing research and development investments by pharmaceutical companies, is significantly contributing to the expansion of the cell and gene therapy manufacturing market. According to the GLOBOCAN 2020 data published by the International Agency for Research on Cancer (IARC), the global cancer burden has risen to 19.3 million cases, underscoring the escalating need for advanced therapeutic solutions such as gene therapy.

Furthermore, the global prevalence of osteoporosis was estimated at 18.3%, as detailed in a comprehensive study published in the Journal of Orthopedic Surgery and Research in October 2021, titled "The Worldwide Prevalence of Osteoporosis in the World: A Comprehensive Systematic Analysis and Meta-analysis." Stem cell-based treatments for osteoporosis present promising potential to mitigate fracture risk. As orthopedic conditions continue to become more widespread, the demand for specialized cell and gene therapy manufacturing services is projected to rise, thereby supporting sustained market growth.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Challenges:
A key obstacle confronting the cell and gene therapy bio-manufacturing market is the high cost associated with these advanced treatments. The substantial financial burden placed on patients, healthcare systems, and insurance providers continues to restrict broader market adoption. For instance, in May 2022, the U.S. Food and Drug Administration (FDA) approved a chimeric antigen receptor (CAR) T-cell therapy for pediatric and young adult patients with refractory or relapsed B-cell precursor acute lymphoblastic leukemia, with a single dose priced at approximately USD 475,000. Such elevated treatment costs have hindered widespread accessibility, thereby limiting market expansion.

Regional Trends:
North America is anticipated to dominate the cell and gene therapy bio-manufacturing market in terms of revenue share and is expected to exhibit a strong compound annual growth rate (CAGR) in the coming years. This growth is primarily driven by the increasing incidence of infectious diseases and a rapidly aging population across the region. Gene therapies are extensively employed in diagnostics, therapeutics, drug discovery, and oncology-related research, with the United States representing a major hub due to its high disease burden. Consequently, North America is projected to experience elevated demand for cell and gene therapies, supported by its expanding patient base and advanced healthcare infrastructure.

Recent Developments:
• In January 2022, AllogeneTherapeutics Inc and AntionBiosciences Inc. formed an exclusive collaboration and global license agreement for Antion's miRNA technology (miCAR) to advance multiplex gene silencing as an additional tool in the development of next-generation allogeneic CAR T products.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1692

Segmentation of Cell and Gene Therapy Bio-manufacturing Market-
By Product Type-
• Consumables
o Culture Supplements
 Media
 Serum
 Macronutrients
o Single-Use Liquids
o Cell Culture Reagents
o Cell Quantification Kits
• Equipment
o Bioreactors/Fermenters
 Continuous Bioreactors
 Single-Use Bioreactors
o Mixing Systems
o Cell Counters
o Cell Sorters
o Centrifuges
o Incubators
o Biosafety Cabinets
o Freezers
o PCR Systems
o Transfection Systems
o Storage Tanks
o Others
• Software Solutions
By Usage-
• Commercial Stage Manufacturing
• Research Stage Manufacturing
By Application-
• Upstream Processing
o Formulation and Hydration
o Cell Culture Processing
• Harvesting
• Downstream Processing
o Separation and Filtration
o Fill and Finish Operations
By End-User-
• Life Science Companies
o Equipment
o Consumables
o Software Solutions
• Contract Research Organizations (CROs)
o Equipment
o Consumables
o Software Solutions
• Contract Manufacturing Organizations (CMOs)
o Equipment
o Consumables
o Software Solutions
• Cell Banks
o Equipment
o Consumables
o Software Solutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/cell-and-gene-therapy-bio-manufacturing-market/1692

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.